Regeneron Pharma (REGN) PT Raised to $925 at Barclays
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $801.82 -0.26%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Barclays analyst Carter Gould raised the price target on Regeneron Pharma (NASDAQ: REGN) to $925.00 (from $900.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Northern Star Resources (NST:AU) (NESRF) PT Lowered to AUD19 at RBC Capital
- Citi Upgrades Osotspa (OSP:TB) (OSOPF) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
